Discover key insights from Vivos Therapeutics’ Q3 2025 earnings: strategic growth, 76% revenue surge, and future outlook in sleep disorder treatment.
"It allows young adults with autism to maintain necessary supports during a critical transition period in their life." ...
The U.S. Food and Drug Administration (FDA) has granted fast track designation to DPTX3186, a first in class oral condensate ...
Q3 2025 Earnings Call November 19, 2025 5:00 PM ESTCompany ParticipantsBradford Amman - CFO, Treasurer & SecretaryR.
More than 30 babies in 15 states have been sickened in a growing outbreak of infant botulism linked to recalled ByHeart ...
The San Diego County Board of Supervisors authorized support on Tuesday for lawsuits protecting access to women’s health ...
Health insurers have long argued that prior authorization — when health plans require approval from an insurer before someone receives treatment — reduces waste and fraud.
In the early 1980s, men and women in the prime of their lives began arriving at Walter Reed Medical Center, wrecked by a disease for which we had no name, no cause and no hope. As an infectious ...
A mother who felt pressured by her husband to take the abortion pill at nine weeks into her pregnancy says a Las Vegas ...
Oregon lawmakers are allocating $7.5 million in emergency funds to Planned Parenthood clinics after federal funding was ...
NeighborHealth announced today the launch of a new partnership with Dana-Farber Cancer Institute, bringing world-renowned cancer expertise directly to NeighborHealth patients to help close persistent ...